Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 7 recruiting now early-phase tilt small index

Psychiatric Disorder: early-phase trial registry

7 of 10 indexed Psychiatric Disorder trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,724 of 28,707 conditions by registered trial count.

10 US clinical trials · 7 currently recruiting · #1,724 of 28,707 conditions by registered trial count

Psychiatric Disorder: 10 US clinical trials tracked, 7 recruiting.

Psychiatric Disorder is the subject of 10 registered US clinical trials on ClinicalTrials.gov, 7 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Brigham and Women's Hospital, running 3 of these trials.

Enrollment posture brief

Registry condition psychiatric-disorder

OPEN 7 | RECR 70% | LATE 0 | EARLY 4 | RANK #1724 | SPON 3

Nearest open-share peer: Advanced Solid Tumor (70% recruiting · 190 trials)

Acute Leukemia of Ambiguous 80%Psychiatric Disorder (this)70%Achondroplasia40%Accelerated Phase Chronic My20%Accidental Fall20%
Open-enrollment share among volume-matched conditions near Psychiatric Disorder

Psychiatric Disorder lists 7 open slots (70% of 10 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Psychiatric Disorder on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Psychiatric Disorder is recruiting above its size-band peers.

    7 of 10 indexed trials (70%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Psychiatric Disorder research.

    Brigham and Women's Hospital accounts for 3 of 10 trials (30%). 8 distinct sponsors appear on at least one study for this condition label.

  3. Typical Psychiatric Disorder enrolment sits around 100 participants.

    Median target enrolment is 100 among the 10 trials that report a genuine target (sentinel values excluded). 5 of those (50%) plan for fewer than 100 participants.

  4. Psychiatric Disorder research is mostly interventional.

    7 interventional and 3 observational studies make up this index (70% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 12Phase 22

Open and recent trials

10 total, page 1 of 1

RECRUITING 500 participants

Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders

Southwest Autism Research & Resource Center

NCT04322734

RECRUITING Phase 2 180 participants

Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness

Brigham and Women's Hospital

NCT06376734

RECRUITING Phase 1 120 participants

HNC: Human Neural Circuits Electrophysiology During Cognition

Stanford University

NCT05962424

RECRUITING 100 participants

Neural Correlates of Psychiatric Disorders

Vanderbilt University Medical Center

NCT04725409

RECRUITING NA 40 participants

External Facilitation to Increase Prescribing of AUD Medications in the Psychiatric Setting

University of Maryland, Baltimore

NCT07053098

RECRUITING NA 40 participants

Electrotherapy Stimulation Together With Life Coaching for the Support of Burnout Symptoms in Healthcare Workers

Roswell Park Cancer Institute

NCT06977503

RECRUITING NA 25 participants

Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians

Fred Hutchinson Cancer Center

NCT07282158

ACTIVE NOT RECRUITING Phase 2 40 participants

Individualized Functional Connectivity Targeting in aiTBS for Depression

Brigham and Women's Hospital

NCT05680727

ACTIVE NOT RECRUITING Early Phase 1 10 participants

Testing a Transdiagnostic TMS Treatment Target

Brigham and Women's Hospital

NCT06282146

COMPLETED 223 participants

Computerized Screening for Comorbidity in Adolescents With Substance or Psychiatric Disorders

Center for Psychological Consultation

NCT01866956

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 2

Named interventions

Most-linked intervention names on Psychiatric Disorder records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

transcranial magnetic stimulation Procedure
2 trials
Sham Intervention Procedure
1 trials
Health and Wellness Coach Behavioral
1 trials
Cranial Electrical Stimulation (CES) Procedure
1 trials
Informational Intervention Other
1 trials
Transcranial magnetic stimulation Device
1 trials
Ketamine Hydrochloride Drug
1 trials
Interview Other
1 trials

US sites by state

Facility locations filed on Psychiatric Disorder trials. A trial with sites in several states counts in each.

Massachusetts 3 trials
New York 2 trials
Maryland 2 trials
California 2 trials
Washington 1 trials
Tennessee 1 trials
Pennsylvania 1 trials
Arizona 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Psychiatric Disorder page

10 registered trials, 7 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Psychiatric Disorder condition card totals 10 registered trials; most-linked intervention transcranial magnetic stimulation; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.